Literature DB >> 1504016

Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells.

P L Chen1, Y Chen, B Shan, R Bookstein, W H Lee.   

Abstract

Mutational inactivation of the retinoblastoma gene (RB) is an invariant feature of the childhood eye cancer retinoblastoma and of tumor cells derived therefrom. In a previous study, retrovirus-mediated transfer of wild-type RB into cultured retinoblastoma cells resulted in a marked enlargement and reduced growth rate of these cells, as well as loss of their tumorigenic properties in nude mice. It was therefore difficult to separate the proposed growth-suppressing and tumor-suppressing activities of RB protein. Here, we show that clones of RB-reconstituted retinoblastoma cells can be isolated that stably express apparently normal RB protein for at least 20 months of continuous culture. These clones were indistinguishable from nonreconstituted cells by multiple parameters including morphology, growth rate, and cell cycle distribution. Despite similar phenotypes in culture, clones with stable RB expression were uniformly nontumorigenic in nude mice, whereas those that lost such expression regained their tumorigenic properties. These results indicate that the tumorigenicity of these cells is entirely determined by the presence or absence of exogenous RB protein expression and that suppression of tumorigenicity is distinct from inhibition of cellular growth in culture.

Entities:  

Mesh:

Year:  1992        PMID: 1504016

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.

Authors:  B Shan; X Zhu; P L Chen; T Durfee; Y Yang; D Sharp; W H Lee
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  G1 arrest and down-regulation of cyclin E/cyclin-dependent kinase 2 by the protein kinase inhibitor staurosporine are dependent on the retinoblastoma protein in the bladder carcinoma cell line 5637.

Authors:  J B Schnier; K Nishi; D W Goodrich; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock.

Authors:  C F Chen; Y Chen; K Dai; P L Chen; D J Riley; W H Lee
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator.

Authors:  L I Chen; T Nishinaka; K Kwan; I Kitabayashi; K Yokoyama; Y H Fu; S Grünwald; R Chiu
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

Review 5.  The cell cycle and the retinoblastoma protein family.

Authors:  M E Ewen
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

6.  Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6.

Authors:  P L Chen; D J Riley; S Chen-Kiang; W H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 7.  Tumor suppressor genes and their roles in breast cancer.

Authors:  L A Cox; G Chen; E Y Lee
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  The transcription factor E2F-1 mediates the autoregulation of RB gene expression.

Authors:  B Shan; C Y Chang; D Jones; W H Lee
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  Rb induces a proliferative arrest and curtails Brn-2 expression in retinoblastoma cells.

Authors:  David Cobrinik; Richard O Francis; David H Abramson; Thomas C Lee
Journal:  Mol Cancer       Date:  2006-12-12       Impact factor: 27.401

10.  The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing.

Authors:  T Durfee; M A Mancini; D Jones; S J Elledge; W H Lee
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.